Rafoxanide Market

Rafoxanide Market Size, Share & Industry Analysis, By Source (Chemical Synthesis, Contract Manufacturing, In-house Production), By Key End-User Industry (Pharmaceuticals, Veterinary Clinics, Livestock Farming, Animal Health Companies), and Forecast, 2025–2035

The global Rafoxanide market is projected to grow at a CAGR of 5.1% during the forecast period, driven by its established role in veterinary medicine for treating parasitic infections in livestock. Rafoxanide is a halogenated salicylanilide anthelmintic effective against liver flukes, gastrointestinal roundworms, and other internal parasites. Its broad-spectrum efficacy and favorable safety profile make it a key agent in livestock productivity and health management.

Regionally, North America currently dominates the market owing to advanced veterinary healthcare practices, widespread livestock deworming protocols, and supportive regulatory approvals. Certainly, the Asia-Pacific region is expected to experience the fastest growth, fueled by expanding commercial animal farming, rising protein demand, and growing awareness of zoonotic parasite control. Europe also maintains a strong market presence with its emphasis on food safety, animal welfare, and regulated antiparasitic drug use.

The Rafoxanide market report provides detailed insights into synthesis methods, scalability of production, cost-effective veterinary formulations, and regional regulatory frameworks. As the global livestock sector evolves to meet rising demand for safe and efficient meat production, Rafoxanide remains a critical input for pharmaceutical companies, veterinary clinics, animal health firms, and livestock producers aiming to enhance productivity and disease control.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Rafoxanide
  • Key End-User Industrys & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Source
    • Chemical Synthesis
    • Contract Manufacturing
    • In-house Production
  • Key End-User Industry
  • Pharmaceuticals
  • Veterinary Clinics
  • Livestock Farming
  • Animal Health Companies
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Trade Analysis
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, and Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Production Capacity
  • Company Profiles & Key Developments
    • Tocris Bioscience
    • Merck KGaA (MilliporeSigma)
    • Sigma-Aldrich
    • MedChemExpress
    • LGC Standards / Toronto Research Chemicals
    • Atom Pharma
    • Sai Life Sciences Ltd.
    • Hangzhou Keying Chem Co., Ltd.
    • Finetech Industry Limited
    • Amadis Chemical Company Ltd.
    • BOC Sciences
    • ChemScence
    • Jigs Chemical Ltd.
    • Apollo Scientific
    • AK Scientific, Inc.
    • Seebio Biotech (Shanghai) Co., Ltd.
    • GLR Innovations
    • Aarti Drugs Ltd.
    • Adani Pharmachem Pvt. Ltd.
    • Combi-Blocks Inc.
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is a Rafoxanide?
Rafoxanide is a halogenated salicylanilide anthelmintic used primarily in veterinary medicine. It is effective against liver flukes, gastrointestinal nematodes, and other parasitic infections in livestock such as cattle and sheep. Its broad-spectrum action and low toxicity make it suitable for routine deworming.
What is the market size for Rafoxanide?
The global Rafoxanide API market is projected to grow at a CAGR of 5.1% during the forecast period of 2025–2035. The market is steadily expanding due to increasing demand for effective antiparasitic agents in livestock and poultry farming.
What are the drivers for the Rafoxanide Market?
Key growth drivers include the rise in parasitic infections among livestock, growing emphasis on food safety and animal health, and the expanding livestock industry in emerging economies. The increasing awareness of productivity-linked parasite control is also contributing to demand.
Who are the key players operating in the Rafoxanide Market?
Major players include Merck KGaA (MilliporeSigma), MedChemExpress, Atom Pharma, LGC Standards, BOC Sciences, Tocris Bioscience, and Apollo Scientific.
Which region would exhibit the fastest growth in the Rafoxanide Market?
The Asia-Pacific region is expected to exhibit the fastest growth, driven by the expansion of commercial livestock farming, growing meat consumption, and increased awareness of animal disease prevention in countries like India, China, and Vietnam.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.